Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells-Reference-Cited by-同舟云学术

Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells

Published:2023-06 Issue: Volume:32 Page:322-339
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Tristán-Manzano María,Maldonado-Pérez Noelia,Justicia-Lirio Pedro,Cortijo-Gutierréz Marina,Tristán-Ramos Pablo,Blanco-Benítez Carlos,Pavlovic Kristina,Aguilar-González Araceli,Muñoz Pilar,Molina-Estevez Francisco J.,Griesche Valerie,Marchal Juan Antonio,Heras Sara R.,Benabdellah Karim,Martin Francisco^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference67 articles.

1. Current landscape of clinical development and approval of advanced therapies;Iglesias-Lopez;Mol. Ther. Methods Clin. Dev.,2021

2. Direct control of CAR T cells through small molecule-regulated antibodies;Park;Nat. Commun.,2021

3. Remote controlled CARs: towards a safer therapy for leukemia;June;Cancer Immunol. Res.,2016

4. A tet-on inducible system for controlling CD19-chimeric antigen receptor expression upon drug administration;Sakemura;Cancer Immunol. Res.,2016

5. Emerging approaches for regulation and control of CAR T cells: a mini review;Brandt;Front. Immunol.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects;Frontiers in Immunology;2024-07-18

2. DGCR8haploinsufficiency leads to primate-specific RNA dysregulation and pluripotency defects;2024-05-03

3. First-in-classTransactivator-Free, Doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B-cell lymphomas;2024-01-25